Navigation Links
New bilateral pilot opportunity will fund collaborations between US and UK bioscience researchers
Date:3/12/2014

This Pilot opportunity is designed to make it easier for research teams comprised of scientists from the United States and the United Kingdom to manage funding logistics and to simultaneously obtain funding from both countries. It is funded by the U.S. National Science Foundation's (NSF) Directorate for Biological Sciences and the U.K.'s Biotechnology and Biological Sciences Research Council (BBSRC).

This Pilot opportunity will use a simplified, flexible review process that will allow U.S./U.K. research teams to submit a single proposal that will undergo a single review process by only one of the partner agencies. Successful proposals will be funded by both NSF and the BBSRC.

Cora B. Marrett, acting director of NSF, said, "Although NSF has always funded U.S. scientists involved in international collaborations, such collaborations have become increasingly important, partly because of the rapid globalization of research. The many benefits of this Pilot opportunity will include better coordination of funding for U.S./U.K. research teams and increased bilateral awareness of scientific strengths and advancements between the U.S. and U.K. funding agencies."

Jackie Hunter, BBSRC chief executive, said, "Partnerships are vital to U.K. bioscience, offering the opportunity to combine resources and expertise to tackle global challenges. As funders, we are working to reduce some of the barriers encountered by researchers when working with international partners. This pilot is an important step that will help to streamline the collaborative funding process between NSF and BBSRC, making applications easier for those in our community working with the U.S."

The Pilot opportunity was created under a Memorandum of Understanding between NSF and the U.K.'s research councils, which support research partnerships between the two countries. The Pilot opportunity is designed to reduce obstacles that have traditionally been faced by researchers wishing to form international teams. These obstacles include identifying appropriate funding agencies; risking "double jeopardy," where one country's funding agency decides to fund an international team's research proposal, but the partner country does not; and dealing with the different timetables of different funding agencies.

The first step in applying for funding under The Pilot opportunity will be for each research team to select a lead agency based on whether its proposed research would fall more within the scope of NSF'S Directorate for Biological Sciences or that of the BBSRC. Then, each team will submit to its proposed lead agency an Intention to Submit (ITS) that summarizes its proposed research, funding request and other associated information. These documents will be reviewed in August 2014 and August 2015.

Based on each team's ITS, the team's lead agency will determine whether the team will be invited to submit a full proposal. Full proposals will be reviewed in fall 2014 and fall 2015; these reviews will be conducted according to the review criteria of each team's lead agency. Proposals that cover systems biology, computational biology, bioinformatics and synthetic biology (the latter, only for fall 2015 submissions) will be eligible for consideration.

Although the review criteria of NSF and BBSRC are not identical, both agencies' criteria include evaluations by invited reviewers on proposals' scientific or intellectual merit as well as on their broader societal impacts. The decision made by the lead agency on each proposal will be discussed with the partner agency. If a research team receives an award, its U.S. researchers will be funded by NSF, and its U.K. researchers will be funded by the BBSRC.


'/>"/>

Contact: Lily Whiteman
lwhitema@nsf.gov
703-292-8310
National Science Foundation
Source:Eurekalert

Related biology news :

1. 5-limbed brittle stars move bilaterally, like people
2. Brain on autopilot
3. Pilot program to let US high-school students experience Antarctic science at a Chilean station
4. Center for Clinical and Translational Science awards new pilot grants
5. Study questions the role of kinship in mass strandings of pilot whales
6. Bioliq pilot plant: Successful operation of high-pressure entrained flow gasification
7. ImpactStory metrics of academic research outreach piloted by Pensoft Publishers
8. Pilot Results Move GHX Closer to Delivery of Healthcare Industrys First Implantable Device Supply Chain Solution
9. Cinega de Santa Clara unchanged after pilot run of Yuma Desalting Plant
10. The first pilot wastewater treatment plant with integrated wood production opened in Mongolia
11. New insights into cancer evolution help define screening window of opportunity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
Breaking Biology Technology: